Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer

Stock Information for Orange County Bancorp Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Orange County Bancorp Inc

Orange County Bancorp, Inc. Declares Cash Dividend
Orange County Bancorp, Inc. Announces Record Third Quarter 2025 Results
Hudson Valley Investment Advisors Rebrands to Orange Investment Advisors, Launching a New Era of Unified Financial Services, Corporate Integration, and Growth in Additional Markets
Orange County Bancorp, Inc. Declares Cash Dividend
Orange County Bancorp, Inc. Announces Record Second Quarter 2025 Earnings
Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaboration Selected to Advance into IND-Enabling Studies
Orange Bank & Trust Promotes Chief Operating Officer, Elizabeth Jones to Executive Vice President
Orange County Bancorp, Inc. Announces Closing of Overallotment Option and Issuance of 258,064 Shares of Common Stock

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.